Structure analysis based identification of novel anti-hiv drugs

Projektinformationen

ID Finanzhilfevereinbarung: QLK2-CT-2000-41485

Projekt abgeschlossen

Startdatum 20 Dezember 2000

Enddatum 19 Dezember 2001

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 29 500,00

EU-Beitrag € 22 125,00

Koordiniert durch

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S
Denmark

Ziel

The present project combines bio informatics approaches with powerful experimental techniques for revealing protein/protein interactions and the efficiency of inhibitor binding with focus on selected HIV proteins. The project includes a novel, massive use of protein structure models for determination of the structural variability of a very large number of mutants, with the aim of developing therapeutic intervention against HIV that can cope with the substantial mutation capability of the virus.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › microbiology › virology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• natural sciences › biological sciences › genetics › mutation

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

EAW - Exploratory awards

Koordinator

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S

• EU-Beitrag: Keine Daten
• Adresse: Agern Alle 3 ; 2970 HOERSHOLM ; Dänemark
• Gesamtkosten: Keine Daten

Beteiligte (1)

HYBRIGENICS

Frankreich

• EU-Beitrag: Keine Daten
• Adresse: Impasse Reille 3-5 ; 75014 PARIS
• Gesamtkosten: Keine Daten